Evaluation of Clinical, Morphologic and Biochemical Markers in Multiple Sclerosis
NCT04892134 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-10-19
Summary
By combining clinical, morphological and biochemical markers a better understanding of the formation and progression of multiple sclerosis (MS) should be obtained
Conditions
Interventions
- OTHER
-
blood sample
40-50 ml of blood is taken
Sponsors & Collaborators
-
Medical University of Graz
lead OTHER
Principal Investigators
-
Christian Enzinger, Prof · Medical University of Graz
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-10-03
- Primary Completion
- 2024-10-31
- Completion
- 2025-10-31
Countries
- Austria
Study Locations
More Related Trials
-
A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis
NCT01539395 ·Status: WITHDRAWN
-
Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis
NCT03122873 ·Status: COMPLETED
-
Baseline Cortical Haemodynamics in MS
NCT02481882 ·Status: UNKNOWN ·Phase: NA
-
Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder
NCT07304960 ·Status: NOT_YET_RECRUITING
-
Progression of Cognitive and Physical Symptoms in Multiple Sclerosis
NCT00922831 ·Status: WITHDRAWN
-
Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis
NCT00468611 ·Status: TERMINATED ·Phase: PHASE3
-
Pathological Basis of MRI Signal Changes in Multiple Sclerosis
NCT02659956 ·Status: RECRUITING
-
Biomarkers in Multiple Sclerosis
NCT00325988 ·Status: COMPLETED
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study
NCT05426980 ·Status: COMPLETED
-
Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With Gilenya
NCT02137707 ·Status: COMPLETED
-
A Retrospective Study to Understand the Clinical Management of Subjects With Multiple Sclerosis at a Site in Taiwan Over the Last 10 Years
NCT01084798 ·Status: COMPLETED
-
Assessment of Patients With Multiple Sclerosis (MS)
NCT00001156 ·Status: COMPLETED
-
A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis
NCT01541618 ·Status: COMPLETED
-
Immunologic Biomarker Profile of Cerebrospinal Fluid
NCT04202055 ·Status: COMPLETED
-
Cellular microRNA Signatures in Multiple Sclerosis
NCT05290688 ·Status: UNKNOWN ·Phase: NA
-
Risk Factors in Early Multiple Sclerosis
NCT03586986 ·Status: UNKNOWN
-
Analysis of a Biomarker Signature in Patients With Multiple Sclerosis (MS) Treated With Gilenya (FTY720)
NCT02408380 ·Status: UNKNOWN
-
Prediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal Biomarkers
NCT05561621 ·Status: COMPLETED
-
A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668
NCT02313285 ·Status: COMPLETED
-
Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis
NCT06283524 ·Status: COMPLETED
-
Cortical Inhibition in Patients With Multiple Sclerosis
NCT07128160 ·Status: NOT_YET_RECRUITING
-
Psychometric Properties Mobility Measures MS
NCT02339688 ·Status: COMPLETED ·Phase: NA
-
Cerebrovascular Changes in Multiple Sclerosis Patients
NCT03709290 ·Status: UNKNOWN
-
Study of Brain Activations and Physiological Responses Using NeuroBiofeedback in Patients With Multiple Sclerosis
NCT06239090 ·Status: RECRUITING ·Phase: NA